India has approved QDENGA, its first dengue vaccine, marking a significant step in the country’s efforts to combat the mosquito-borne disease that affects hundreds of thousands of people annually.
Unlike some previous dengue vaccine candidates, QDENGA does not require pre-vaccination testing to confirm prior dengue exposure, a factor that had complicated rollout of earlier vaccines in some countries. The approval clears the way for the vaccine to be made available in India, though a timeline for public distribution was not specified.
Dengue remains a major public health concern in India, with seasonal outbreaks placing recurring strain on hospitals during the monsoon months. Health officials have welcomed the approval as a tool that could help reduce the disease burden in coming years.
The clearance is expected to be closely watched by state health departments as they weigh how quickly to incorporate the vaccine into seasonal dengue-prevention efforts once distribution begins.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
http://www.beyondhorizon.in/news.php?breaking-news-july-21-2026